文献速递腹部CTMR

术前化疗和放疗时代的胰腺腺癌分期

Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy.
PubMed 文献 · Radiology · 2018-01-01

本文综述非转移性胰腺导管腺癌新辅助化疗或化疗联合放疗策略下的影像学分期问题。新辅助治疗可使初始影像学评估为局部晚期的肿瘤降期至可切除,但影像评估治疗反应极为复杂,基于肿瘤-血管接触程度的标准血管侵犯预测标准在新辅助治疗后不再有效。

要点

  • 新辅助治疗可使初始影像学局部晚期的胰腺导管腺癌降期至可切除。
  • 基于肿瘤-血管接触程度的标准血管侵犯预测标准在新辅助治疗后不再有效。
  • 影像学诊断性能不足以准确筛选出可能实现负切缘切除的患者。

核心结论

  • 新辅助化疗或化疗联合放疗策略的主要优势在于通过实现负切缘切除来更好地筛选可能从根治性手术中获益的患者,但影像学评估新辅助治疗反应极为复杂,其诊断性能不足以确保准确筛选出可能实现负切缘切除的患者。

研究设计与样本

  • 综述,总结术前化疗和放疗时代胰腺导管腺癌分期的影像学评估问题。

诊断标准与关键数值

  • 基于肿瘤-血管接触程度的标准血管侵犯预测标准在新辅助治疗后不适用。

临床应用与阅片要点

  • 新辅助治疗可使初始影像学局部晚期的肿瘤降期至可切除。
  • 影像学诊断性能不足以准确筛选出可能实现负切缘切除的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic ductal adenocarcinoma (PDA) remains among the most challenging malignancies to treat. At diagnosis, the tumor often already extends beyond the confines of the pancreas, spreading to an extent such that primary surgery with curative intent is very rarely feasible. Considerable momentum is now being given to a treatment strategy involving neoadjuvant chemotherapy or chemotherapy and radiation therapy in patients with nonmetastatic PDA. The main advantage of this strategy is better selection of patients likely to benefit from curative-intent surgery through the achievement of negative resection margins. Patients with rapidly progressive disease are identified and are spared ineffective surgery with its attendant morbidity. Neoadjuvant therapy can downstage tumors classified as locally advanced at initial imaging studies to resectable tumors. However, the imaging study evaluation of the response to neoadjuvant therapy is extremely complex. Thus, the diagnostic performance of imaging studies is not sufficient to ensure the accurate selection of patients in whom negative-margin resection is likely to be achieved. More specifically, standard criteria for predicting vascular invasion, based on the amount of tumor-vessel contact, are not valid after neoadjuvant therapy. ©RSNA, 2018.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Zins M, Matos C, Cassinotto C, et al. Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy. Radiology. 2018. PMID: 29668413. doi:10.1148/radiol.2018171670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。